HH

Howard.D Hai

Venture Capital | Biotech | Incubation & Formation

Shanghai

Invests in

Stages:

Sectors:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $1,500,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Vice President, Investment

    2023

  • Senior Associate, Investment

    2022 - 2023

    Gordian Ventures is a global life sciences venture firm focused on the incubation of companies with extremely high technical barriers to entry. As co-founders, Gordian Ventures works side-by-side with scientist-entrepreneurs whose insights about overcoming technical barriers are often beyond the scope of the traditional biotech funding model. Our role as active co-founders enables Gordian Ventures to provide embedded, hands-on expertise critical to aligning novel concepts and building visionary companies. We collaborate with our scientific co-founders in the quest to surmount previously unbreakable technical barriers and combat previously intractable diseases that have plagued mankind for millennia. Delivering new age solutions to age-old problems means thinking beyond the limitations of a conventional “magic pill” development cycle of identifying a biology, selecting a target, and attempting to produce a drug to resolve a specific aspect of biology. Gordian Ventures and our scientific co-founders are investing in a new archetype to build companies capable of solving the healthcare problems of today and tomorrow. We are moving at a rapid pace beyond frameworks limited to biology and chemistry and are forging ahead to explore uncharted science at the intersections of multiple technologies to create a healthier future for the people of our planet.

  • Vice President

    2023

  • Senior Associate

    2022 - 2023

  • Interim Director of Strategy, Chief of Staff

    2023

  • Investor

    2022 - 2022

2020 - 2022

  • Investor

    2020 - 2022

    Focus on early-stage pre-clinical therapeutics investment opportunities worldwide. Specify in novel biotechnology platform, FIC small molecule/biologics, and cell/gene therapy. Provide cash and in-kind services (equity-for-service).

  • Senior Associate

    2018 - 2020

    - Financial Service - PE/VC Group - Focus on healthcare PE/VC funds - Due Diligence, portfolio valuation, statutory audit, etc.

  • Assistant Consultant

    2017 - 2018